High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification

Contrast Media and Molecular Imaging

Volumn 11, Issue 3, 2016, Pages 245-250

  Barbieri, Sebastiano ^a   Schroeder, Christophe ^a   Froehlich, Johannes M ^a   Pasch, Andreas ^a   Thoeny, Harriet C ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Calciphylaxis; Dentate nucleus; Gadolinium based contrast agent; Globus pallidus; Nephrogenic systemic fibrosis

Indexed keywords

GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; GADOTERIDOL; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BIOACCUMULATION; BLOOD VESSEL CALCIFICATION; CALCEMIC UREMIC ARTERIOLOPATHY; CASE REPORT; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; DENTATE NUCLEUS; DIFFUSION WEIGHTED IMAGING; FEMALE; GLOBUS PALLIDUS; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE PROCESSING; KIDNEY BIOPSY; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LEUKOENCEPHALOPATHY; MIDDLE AGED; NEPHROGENIC SYSTEMIC FIBROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PONTINE CAPILLARY TELANGIECTASIA; PRIORITY JOURNAL; REFLUX NEPHROPATHY; RENOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS; TELANGIECTASIA; VASCULAR DISEASE; BRAIN; CEREBELLUM NUCLEUS; COMPLICATION; DIAGNOSTIC IMAGING; KIDNEY DISEASE; METABOLISM; PROCEDURES;

AGED; BRAIN; CEREBELLAR NUCLEI; CONTRAST MEDIA; FEMALE; GADOLINIUM; GLOBUS PALLIDUS; HUMANS; KIDNEY DISEASES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEPHROGENIC FIBROSING DERMOPATHY; VASCULAR CALCIFICATION;

EID: 84954098111     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1683     Document Type: Article

References (30)

1. Zhou Z, Lu ZR. Gadolinium-based contrast agents for magnetic resonance cancer imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013; 5(1): 1-18. doi:10.1002/wnan.1198.
2. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999; 99(9): 2293-2352.
3. Aime S, Caravan P. Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J Magn Reson Imaging 2009; 30(6): 1259-1267. doi:10.1002/jmri.21969.
4. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006; 21(4): 1104-1108. doi:10.1093/ndt/gfk062.
5. High WA, Ayers RA, Chandler J, Zito G, Cowper SE. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 2007; 56(1): 21-26. doi:10.1016/j.jaad.2006.10.047.
6. Swaminathan S, High WA, Ranville J, Horn TD, Hiatt K, Thomas M, Brown HH, Shah SV. Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis. Kidney Int 2008; 73(12): 1413-1418. doi:10.1038/ki.2008.76.
7. Sanyal S, Marckmann P, Scherer S, Abraham JL. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis -an autopsy-based review. Nephrol Dial Transplant 2011; 26(11): 3616-3626. doi:10.1093/ndt/gfr085.
8. Kanda T, Osawa M, Oba H, Toyoda K, Kotoku J, Haruyama T, Takeshita K, Furui S. High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 2015; 275(3): 803-809. doi:10.1148/radiol.14140364.
9. Radbruch A, Weberling LD, Kieslich PJ, Eidel O, Burth S, Kickingereder P, Heiland S, Wick W, Schlemmer HP, Bendszus M. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 2015; 275(3): 783-791. doi:10.1148/radiol.2015150337.
10. ESUR. European Society of Urogenital Radiology guidelines on constrast media. http://www.esur.org/guidelines/2012 [17 August 2015].
11. Amet S, Launay-Vacher V, Clement O, Frances C, Tricotel A, Stengel B, Gauvrit JY, Grenier N. Reinhardt G, Janus N, Choukroun G, Laville M, Deray G. Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogenique Systemique study. Invest Radiol 2014; 49(2): 109-15. doi:10.1097/RLI.0000000000000000.
12. Ramalho J, Castillo M, AlObaidy M, Nunes RH, Ramalho M, Dale BM, Semelka RC. High signal intensity in globus pallidus and dentate nucleus on unenhanced T1-weighted MR images: evaluation of two linear gadolinium-based contrast agents. Radiology 2015: 150872. doi:10.1148/radiol.2015150872.
13. Errante Y, Cirimele V, Mallio CA, Di Lazzaro V, Zobel BB, Quattrocchi CC. Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Invest Radiol 2014; 49(10): 685-690. doi:10.1097/RLI.0000000000000072.
14. Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2014; 270(3): 834-841. doi:10.1148/radiol.13131669.
15. McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, Williamson EE, Eckel LJ. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 2015; 275(3): 772-782. doi:10.1148/radiol.15150025.
16. Kanda T, Fukusato T, Matsuda M, Toyoda K, Oba H, Kotoku J, Haruyama T, Kitajima K, Furui S. Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 2015; 276(1): 228-232. doi:10.1148/radiol.2015142690.
17. Xia D, Davis RL, Crawford JA, Abraham JL. Gadolinium released from MR contrast agents is deposited in brain tumors: in situ demonstration using scanning electron microscopy with energy dispersive X-ray spectroscopy. Acta Radiol 2010; 51(10): 1126-1136. doi:10.3109/02841851.2010.515614.
18. Song J, Volkov S, Shea CR, Alegre ML, Salgia R, Gregg K, Curran JJ, Woodruff J, Krausz T, Levine JS, Sweiss NJ. Nephrogenic systemic fibrosis associated with stromal and vascular calcification, report of two cases. J Cutan Pathol 2009; 36(Suppl 1): 31-34. doi:10.1111/j.1600-0560.2008.01205.x.
19. Quattrocchi CC, Mallio CA, Errante Y, Cirimele V, Carideo L, Ax A, Zobel BB. Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy. Invest Radiol 2015; 50(7): 470-472. doi:10.1097/RLI.0000000000000154.
20. Darrah TH, Prutsman-Pfeiffer JJ, Poreda RJ, Ellen Campbell M, Hauschka PV, Hannigan RE. Incorporation of excess gadolinium into human bone from medical contrast agents. Metallomics 2009; 1(6): 479-488. doi:10.1039/b905145g.
21. Gibby WA, Gibby KA, Gibby WA. Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy. Invest Radiol 2004; 39(3): 138-142.
22. White GW, Gibby WA, Tweedle MF. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Invest Radiol 2006; 41(3): 272-278. doi:10.1097/01.rli.0000186569.32408.95.
23. Boyd AS, Zic JA, Abraham JL. Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 2007; 56(1): 27-30. doi:10.1016/j.jaad.2006.10.048.
24. Gou BD, Bian S, Zhang TL, Wang K. Gadolinium-promoted precipitation of calcium phosphate is associated with profibrotic activation of RAW 264.7 macrophages. Toxicol In Vitro 2010; 24(6): 1743-1749. doi:10.1016/j.tiv.2010.05.004.
25. Idee JM, Fretellier N, Robic C, Corot C. The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: a critical update. Crit Rev Toxicol 2014; 44(10): 895-913. doi:10.3109/10408444.2014.955568.
26. Chang Y, Kim Y, Woo ST, Song HJ, Kim SH, Lee H, Kwon YJ, Ahn JH, Park SJ, Chung IS, Jeong KS. High signal intensity on magnetic resonance imaging is a better predictor of neurobehavioral performances than blood manganese in asymptomatic welders. Neurotoxicology 2009; 30(4): 555-563. doi:10.1016/j.neuro.2009.04.002.
27. Michalke B, Fernsebner K. New insights into manganese toxicity and speciation. J Trace Elem Med Biol 2014; 28(2): 106-116. doi:10.1016/j.jtemb.2013.08.005.
28. Kim TJ, Kim IO, Kim WS, Cheon JE, Moon SG, Kwon JW, Seo JK, Yeon KM. MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation. AJNR Am J Neuroradiol 2006; 27(6): 1373-1378.
29. Suzuki S, Nishio S, Takata K, Morioka T, Fukui M. Radiation-induced brain calcification: paradoxical high signal intensity in T1-weighted MR images. Acta Neurochir (Wien) 2000; 142(7): 801-804.
30. Adin ME, Kleinberg L, Vaidya D, Zan E, Mirbagheri S, Yousem DM. Hyperintense dentate nuclei on T1-weighted MRI: relation to repeat gadolinium administration. AJNR Am J Neuroradiol 2015. doi:10.3174/ajnr.A4378.